Patents by Inventor Maurice Stroun

Maurice Stroun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for blocking tumour growth
    Patent number: 9555075
    Abstract: The present invention concerns a pharmaceutical composition comprising virtosomes isolated from non-dividing cells or the medium in which the cells are grown, for use in the inhibition of tumor growth and/or prevention of metastases.
    Type: Grant
    Filed: May 29, 2014
    Date of Patent: January 31, 2017
    Assignee: THE FOUNDATION FOR BIOMEDICAL RESEARCH OF LA PAZ UNIVERSITY HOSPITAL (FIBHULP)
    Inventors: Damián Garcia-Olmo, Mariano Garcia-Arranz, Luz Vega Clemente, Peter Brian Gahan, Maurice Stroun
  • METHOD FOR BLOCKING TUMOUR GROWTH
    Publication number: 20150071986
    Abstract: The present invention concerns a pharmaceutical composition comprising virtosomes isolated from non-dividing cells or the medium in which the cells are grown, for use in the inhibition of tumour growth and/or prevention of metastases.
    Type: Application
    Filed: May 29, 2014
    Publication date: March 12, 2015
    Applicant: The Foundation for Biomedical Research of La Paz University Hospital (FIBHULP)
    Inventors: Damián GARCIA-OLMO, Mariano Garcia-Arranz, Luz Vega Clemente, Peter Brian Gahan, Maurice Stroun
  • Method for the detection of cancer
    Patent number: 7700286
    Abstract: The present invention relates to a method for the diagnosis and/or the follow up of the evolution of cancer, which includes the analysis and quantification of over expressed and amplified genes in the plasma/serum of cancer patients or persons suspected to harbor cancer. This is achieved by analyzing together the amount of DNA and RNA of certain genes in the plasma/serum of cancer patients that are the reflection of a gene amplification and/or a gene over expression in comparison to healthy controls.
    Type: Grant
    Filed: January 23, 2006
    Date of Patent: April 20, 2010
    Inventors: Maurice Stroun, Philippe Anker
  • Cancer diagnosis method
    Patent number: 7163789
    Abstract: The invention concerns a method for the diagnosis and/or the follow up of the evolution of cancer comprising the analysis of the RNA components of the telomerase enzyme present in the plasma or serum of the blood.
    Type: Grant
    Filed: May 16, 2001
    Date of Patent: January 16, 2007
    Inventors: Xu Qi Chen, Maurice Stroun, Philippe Anker
  • Method for the detection of cancer
    Publication number: 20060228727
    Abstract: The present invention relates to a method for the diagnosis and/or the follow up of the evolution of cancer, which includes the analysis and quantification of over expressed and amplified genes in the plasma/serum of cancer patients or persons suspected to harbor cancer. This is achieved by analyzing together the amount of DNA and RNA of certain genes in the plasma/serum of cancer patients that are the reflection of a gene amplification and/or a gene over expression in comparison to healthy controls.
    Type: Application
    Filed: January 23, 2006
    Publication date: October 12, 2006
    Inventors: Maurice Stroun, Philippe Anker
  • Cancer diagnosis method
    Publication number: 20040132019
    Abstract: The invention concerns a method for the diagnosis and/or the follow up of the evolution of cancer comprising the analysis of the RNA components of the telomerase enzyme present in the plasma or serum of the blood.
    Type: Application
    Filed: May 13, 2003
    Publication date: July 8, 2004
    Inventors: Xu Qi Chen, Maurice Stroun, Philippe Anker
  • Method for diagnosing cancers
    Patent number: 5952170
    Abstract: A method of diagnosing and/or monitoring the development of cancer by analyzing the deoxyribonucleic acid (DNA) in blood plasma, and particularly by detecting any gene alterations in cancer cell DNA, e.g. oncogene mutations or deletions, tumour suppressor gene mutations or deletions, or microsatellite alterations.
    Type: Grant
    Filed: June 17, 1996
    Date of Patent: September 14, 1999
    Inventors: Maurice Stroun, Philippe Anker, Valeri Vasioukhin
  • Method for the detection of cancer
    Patent number: RE44596
    Abstract: The present invention relates to a method for the diagnosis and/or the follow up of the evolution of cancer, which includes the analysis and quantification of over expressed and amplified genes in the plasma/serum of cancer patients or persons suspected to harbor cancer. This is achieved by analyzing together the amount of DNA and RNA of certain genes in the plasma/serum of cancer patients that are the reflection of a gene amplification and/or a gene over expression in comparison to healthy controls.
    Type: Grant
    Filed: April 13, 2012
    Date of Patent: November 12, 2013
    Assignee: Guardant Health, Inc.
    Inventors: Maurice Stroun, Philippe Anker
  • Method for the detection of cancer
    Patent number: RE49542
    Abstract: The present invention relates to a method for the diagnosis and/or the follow up of the evolution of cancer, which includes the analysis and quantification of over expressed and amplified genes in the plasma/serum of cancer patients or persons suspected to harbor cancer. This is achieved by analyzing together the amount of DNA and RNA of certain genes in the plasma/serum of cancer patients that are the reflection of a gene amplification and/or a gene over expression in comparison to healthy controls.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: June 6, 2023
    Assignee: Guardant Health, Inc.
    Inventors: Maurice Stroun, Philippe Anker